DailyIQ
Last updated 1 hour ago

FMC·FMC Corporation

$.
+. (+.%)
High
$13.24
Open
$13.09
Market Cap
1.64B
52W High
$44.78
Low
$13.02
P. Close
$13.11
P/E
-
52W Low
$12.17
Fwd P/E
60.41
Mean Target
-
Technical Score (1D)
41
SELL
News Sentiment
45
MIXED
FMC Corporation announced a significant $1.2 billion debt issuance, raising capital through senior secured notes maturing in 2031 with an 8% interest rate. This move, intended to repurchase existing debt and fund general corporate purposes, increases the company's debt burden and has negatively impacted investor sentiment. This development follows a period where FMC's one-year shareholder return has fallen by 64.2%, coinciding with a reported annual net loss. Despite these challenges, current market narratives suggest the stock may be undervalued, with valuation models indicating a fair value above its recent trading price. Investors will be watching to see how the increased debt load affects future profitability and if the company can successfully manage its financial obligations. The market will also be focused on any further updates regarding the use of proceeds from the debt issuance and any signs of operational improvement.
Earnings Summary
FMC Corporation is a global agricultural sciences company focused on developing, marketing, and selling crop protection products, including insecticides, herbicides, and fungicides, to help farmers improve crop yields and quality. The company operates across a wide range of agricultural markets globally. FMC has demonstrated a mixed performance in recent quarters, with EPS beating estimates in Q4 2024 ($1.79 actual vs $1.60442 estimate), Q1 2025 ($0.18 actual vs $0.09247 estimate), Q2 2025 ($0.69 actual vs $0.62063 estimate), and Q3 2025 ($0.89 actual vs $0.85479 estimate), but missing in Q4 2025 ($1.20 actual vs $1.2146 estimate). Revenue has also shown variability, with Q4 2024 revenue at $1.2243 billion and Q1 2026 revenue at $758.6 million. The company reported a net loss in Q1 2026, with EPS at -$0.23 (vs -$0.3354 estimate), which was an improvement over the estimate. Recent news indicates a downgrade to 'Hold' following the sale of its India business, with concerns about high net debt and declining EBITDA. Despite these challenges, FMC reaffirmed its 2026 sales guidance and is prioritizing R&D for new product innovation, particularly biological solutions. Investors will be watching for FMC's execution on its guidance amidst pricing pressures, its strategic exit from the Indian market, and its ability to manage its debt levels and improve its financial leverage.

EPS

EstBeatMiss
$-0.57$-0.06$0.44$0.94$1.45Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$0.21 - -
Q1'26$-0.34$-0.23+31.4%
Q4'25$1.21$1.20-1.2%
Q3'25$0.85$0.89+4.1%
Q2'25$0.62$0.69+11.2%
Q1'25$0.09$0.18+94.7%

Revenue

EstBeatMiss
$449M$651M$852M$1.1B$1.3BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$917M - -
Q1'26$752M$759M+0.9%
Q4'25$1.2B$1.1B-6.8%
Q3'25 - $542M -
Q2'25 - $1.1B -
Q1'25 - $791M -

Market Data

FMC Stock Snapshot

FMC is currently trading at $13.20, giving FMC Corporation a market cap of 1.64B. Today's range spans $13.02–$13.24, with shares opening at $13.09 and moving up $0.09 (0.7%) from the prior close. DailyIQ's technical score sits at 41/100 (HOLD) with a news sentiment reading of 45/100.

Over the past year FMC has traded between $12.17 and $44.78 - the current price is +8.5% off the 52-week low and -70.5% from the high.

FMC is a small-cap Basic Materials stock (1.64B market cap) in a non-trending phase. Score: 41/100 (HOLD). Sentiment: neutral (45/100). Price: $13.20 (near 52-week lows in $12.17–$44.78). At this capitalization tier, HOLD signals combined with neutral news flow often indicate a period of institutional disinterest - the setup can stay neutral or deteriorate until a catalyst restores conviction.

The absence of strong institutional sponsorship makes FMC's HOLD signal (41/100) more consequential than the same signal in a larger name — at 1.64B in Basic Materials market cap, there are fewer natural buyers to absorb selling pressure, which means the $12.17–$44.78 range's lower bound becomes a sharper test of the thesis. Sentiment at 45/100 (neutral) and price at $13.20 (near 52-week lows) don't yet suggest stabilization is imminent.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles
Loading latest news…